Search - tctmd.com

Displaying 1 - 20 of 272

Sort: Relevancy | Date

News Industry News

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

December 14, 2020

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

News Industry News

Breakthrough Cardiac-Telemedicine™ device, now CE-Cleared.

September 15, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

Corvent Medical, A Coridea Portfolio Company, Closes $4.5m Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

May 11, 2020

News Industry News

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

March 05, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

FIND FH® Makes Identifying and Diagnosing Individuals at Genetic Risk for Early Heart Attacks and Stroke Possible

October 21, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Industry News

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

July 29, 2019

News Industry News

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

July 25, 2019

News Industry News

SENSE Data Shows DX System is Equivalent to Dual-Chamber ICDs and Superior to Single-Chamber in AHRE Detection

July 22, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III

July 08, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

Advertisement

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

Breakthrough Cardiac-Telemedicine™ device, now CE-Cleared.

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Corvent Medical, A Coridea Portfolio Company, Closes $4.5m Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

Thrombolex Bashir® Endovascular Catheter First-In-Human (FIH) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

FIND FH® Makes Identifying and Diagnosing Individuals at Genetic Risk for Early Heart Attacks and Stroke Possible

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

preCARDIA Enrolls First Patient in Early Feasibility Study

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

SENSE Data Shows DX System is Equivalent to Dual-Chamber ICDs and Superior to Single-Chamber in AHRE Detection

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content